Clinical trial
The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic…
NCT03059979 · Radboud University Medical Center, Other · Unknown status
Key facts
| NCT number | NCT03059979 |
|---|---|
| Title | The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc ) |
| Official title | Hit Hard and Early. The Effect of High Dose Methylprednisolone on Nailfold Capillary Changes and Biomarkers in Early SSc: a 12-week Randomised Explorative Double-blind Placebo-controlled Trial. |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Unknown status |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Systemic Sclerosis, Raynaud Phenomena |
| Intervention type | Drug, Other |
| Interventions | Methylprednisolone, sodium chloride |
| Enrollment | 30 |
| Start date | Jan 1, 2017 |
| Primary completion | Jul 1, 2021 |
| Completion | Jul 1, 2021 |
| First posted | Feb 23, 2017 |
| Last update posted | Nov 29, 2019 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: